Suppr超能文献

骨质疏松症与骨折预防中的关键问题及当前挑战。未满足需求概述。

Critical issues and current challenges in osteoporosis and fracture prevention. An overview of unmet needs.

作者信息

Lems Willem F, Raterman Hennie G

机构信息

Amsterdam Rheumatology and Immunology Centre, VU University Medical Centre and Reade, P.O. Box 7057 1007 MB Amsterdam, The Netherlands.

Amsterdam Rheumatology and Immunology Centre, VU University Medical Centre and Reade, North West Clinics, Alkmaar, The Netherlands.

出版信息

Ther Adv Musculoskelet Dis. 2017 Dec;9(12):299-316. doi: 10.1177/1759720X17732562. Epub 2017 Oct 27.

Abstract

Osteoporosis is a silent disease with increasing prevalence due to the global ageing population. Decreased bone strength and bone quality is the hallmark of osteoporosis which leads to an increased risk of fragility fractures in elderly. It has been estimated that approximately ~50% of women will suffer during their lifetime from an osteoporotic fracture. This must be considered as a major health concern, as it has previously been established that fragility fracture has been associated with decreased quality of life due to increased disability, more frequent hospital admission and most importantly, osteoporotic fractures have been related to an augmented mortality risk. Anti-osteoporotic drugs are available for improving bone quality. Although there is access to these therapeutic options, there remain multiple unmet needs in the field of osteoporosis and fracture care, for example, the primary prevention of osteoporosis in young individuals (to reach a high peak bone mass), the optimization of the use of imaging techniques [dual-energy X-ray absorptiometry (DXA), vertebral fracture assessment (VFA) and new techniques measuring bone quality], the use of nonmedical treatment options and surgical techniques of fracture healing. In this review, we will discuss topics that play a role in the occurrence and prevention of fractures, and we give an overview of and insight into the critical issues and challenges around osteoporosis and fracture prevention.

摘要

骨质疏松症是一种隐匿性疾病,随着全球人口老龄化,其患病率不断上升。骨强度和骨质量下降是骨质疏松症的标志,这会导致老年人发生脆性骨折的风险增加。据估计,约50%的女性一生中会遭受骨质疏松性骨折。这必须被视为一个主要的健康问题,因为此前已经证实,脆性骨折与生活质量下降有关,原因包括残疾增加、住院频率更高,最重要的是,骨质疏松性骨折与死亡风险增加有关。抗骨质疏松药物可用于改善骨质量。尽管有这些治疗选择,但骨质疏松症和骨折护理领域仍存在多个未满足的需求,例如,年轻个体骨质疏松症的一级预防(以达到较高的峰值骨量)、成像技术[双能X线吸收法(DXA)、椎体骨折评估(VFA)和测量骨质量的新技术]使用的优化、非药物治疗选择的使用以及骨折愈合的手术技术。在本综述中,我们将讨论在骨折发生和预防中起作用的主题,并概述和深入探讨围绕骨质疏松症和骨折预防的关键问题与挑战。

相似文献

7
8
9
10

引用本文的文献

6
Responders and non-responders to romosozumab treatment.罗莫单抗治疗的反应者和无反应者。
J Bone Miner Metab. 2025 Jan;43(1):18-21. doi: 10.1007/s00774-024-01570-y. Epub 2024 Dec 7.
10
Stem Cells in Bone Tissue Engineering: Progress, Promises and Challenges.骨组织工程中的干细胞:进展、前景与挑战。
Stem Cell Rev Rep. 2024 Oct;20(7):1692-1731. doi: 10.1007/s12015-024-10738-y. Epub 2024 Jul 19.

本文引用的文献

2
The calcium and vitamin D controversy.钙与维生素D之争
Ther Adv Musculoskelet Dis. 2017 May;9(5):107-114. doi: 10.1177/1759720X16685547. Epub 2017 Mar 26.
4
Quality in dual-energy X-ray absorptiometry scans.双能 X 射线吸收法扫描中的质量。
Bone. 2017 Nov;104:13-28. doi: 10.1016/j.bone.2017.01.033. Epub 2017 Jan 31.
5
Combined Pharmacologic Therapy in Postmenopausal Osteoporosis.绝经后骨质疏松症的联合药物治疗。
Endocrinol Metab Clin North Am. 2017 Mar;46(1):193-206. doi: 10.1016/j.ecl.2016.09.008. Epub 2016 Nov 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验